A discussion of the new controversial ACC/AHA guideline updates, which reduced the level of evidence for CABG as a treatment for CAD patients with three-vessel disease and normal LV function. The panel provides a rebuttal on the benefits of CABG versus medical therapy and the reduction in class designation for CABG, as well as the use of the ISCHEMIA and other similar trials for drawing such comparative evidence conclusions.
The information in this content is intended only for healthcare professionals in countries where these Medtronic products and therapies are approved or available for use. The content may not be approved for use in your specific region or country. Please review applicable product labeling for your country for indications and instructions prior to viewing.
DISCLAIMER: The information in this content is intended only for healthcare professionals in countries where these Medtronic products and therapies are approved or available for use. The content may not be approved for use in your specific region or country. Please review applicable product labeling for your country for indications and instructions prior to viewing. If not approved, please exit this page.
Recent happenings and trends in mitral valve repair (Segment 4)
Published on
In this series, Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, Dr. Eugene Grossi of New York University, Dr. Robert L. Smith of Baylor Scott & White in Plano, and Dr. Puja Kachroo from Washington University School of Medicine in St. Louis discuss what has changed and is about to change in the treatment of mitral valve patients. Learn more about the importance of MICS procedures, critical step...
The information in this content is intended only for healthcare professionals in countries where these Medtronic products and therapies are approved or available for use. The content may not be approved for use in your specific region or country. Please review applicable product labeling for your country for indications and instructions prior to viewing.
Recent happenings and trends in mitral valve repair (Segment 3)
Published on
In this series, Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, Dr. Eugene Grossi of New York University, Dr. Robert L. Smith of Baylor Scott & White in Plano, and Dr. Puja Kachroo from Washington University School of Medicine in St. Louis discuss what has changed and is about to change in the treatment of mitral valve patients. Learn more about the importance of MICS procedures, critical step...
The information in this content is intended only for healthcare professionals in countries where these Medtronic products and therapies are approved or available for use. The content may not be approved for use in your specific region or country. Please review applicable product labeling for your country for indications and instructions prior to viewing.
Recent happenings and trends in mitral valve repair (Segment 2)
Published on
In this series, Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, Dr. Eugene Grossi of New York University, Dr. Robert L. Smith of Baylor Scott & White in Plano, and Dr. Puja Kachroo from Washington University School of Medicine in St. Louis discuss what has changed and is about to change in the treatment of mitral valve patients. Learn more about the importance of MICS procedures, critical step...
The information in this content is intended only for healthcare professionals in countries where these Medtronic products and therapies are approved or available for use. The content may not be approved for use in your specific region or country. Please review applicable product labeling for your country for indications and instructions prior to viewing.
